Paragon Approved for Phenylephrine Ophthalmic Solution

Paragon BioTeck announced that the FDA has approved Phenylephrine HCl Ophthalmic Solution.

Phenylephrine HCl is an alpha-1 adrenergic receptor agonist indicated for pupil dilation due to its vasoconstrictor and mydriatic mechanisms of action. Phenylephrine HCl possesses predominantly alpha-adrenergic effects. In the eye, phenylephrine acts locally as a potent vasoconstrictor and mydriatic by constricting ophthalmic blood vessels and the radial muscle of the iris.

RELATED: Omidria Gets FDA Approval

Phenylephrine HCl Ophthalmic Solution is available in 2.5% and 10% strengths through Bausch + Lomb and primary wholesalers.

For more information call (888) 424-1192or visit